is a glp 1 a semaglutide GLP-1 Rx GLP-1 Drug Can Cause Rare,

Lilly said the same day that it plans to submit a Biologics License Application in Q1 2027

Semaglutide (Ozempic, Wegovy): GLP-1 receptor agonist 31-amino acid peptide Position 2: Aib substitution Position 20: Lys acylated with a C18 fatty diacid via a Glu-(AEEA-AEEA) linker Position 28: Arg substitution Tirzepatide (Mounjaro, Zepbound): Dual GIP/GLP-1 receptor agonist 39-amino acid peptide: Position 2 and 13: Aib substitution Position 20: Lys acylated with a C20 fatty diacid via a Glu-(AEEA-AEEA) linker Position 30-39: Amino acid sequence from exenatide Retatrutide: Triple GLP-1/GIP/GCG receptor agonist 39-amino acid peptide: Position 2 and 20: Aib substitution Position 13: Leucine modified with an -methyl group (2-Methylleucine) Position 17: Lys acylated with a C20 fatty diacid via a Glu-(AEEA) linker Position 30-39: Amino acid sequence from exenatide Semaglutide and Tirzepatide are widely available and well-studied, while Retatrutide's long-term effectiveness and safety profile are still being investigated in clinical trials

If medication is needed, selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment

One study also found that discontinuation due to side effects was higher among those taking oral semaglutide compared to those taking injectable semaglutide

Tingling, numbness, or prickling have been reported in retatrutide trials and appear to increase at higher doses